The Agent Orange lawsuit began in 1979 as a class action by Vietnam veterans against the chemical companies that made the herbicide, ended in a $180 million out-of-court settlement in 1984 that the manufacturers paid without admitting liability, and has since shifted almost entirely away from the companies and onto the Department of Veterans Affairs, where consent-decree enforcement, congressional expansions, and a new 2026 sex-discrimination suit now drive who gets paid and for what.
How the Case Started
The original plaintiff was Paul Reutershan, a 28-year-old Vietnam veteran who blamed his chloracne and abdominal cancer on Agent Orange exposure after seeing a 1978 CBS documentary. He sued Dow Chemical, Monsanto, and Diamond Shamrock in New York state court for $10 million and founded Agent Orange Victims International before dying of cancer on December 14, 1978.1Agent Orange Record. The US Lawsuit
Attorney Victor Yannacone took the case over from Reutershan’s original counsel and filed an amended class action complaint on January 8, 1979. The complaint named seven chemical companies: Dow Chemical, Monsanto, Diamond Shamrock, Hercules, Uniroyal, T.H. Agriculture and Nutrition Company, and Thompson Chemical Company.1Agent Orange Record. The US Lawsuit In March 1979, the Judicial Panel on Multidistrict Litigation consolidated the claims and sent them to the Eastern District of New York, where Chief Judge Jack B. Weinstein would preside for decades.2Victor Yannacone Law. Agent Orange Chronicle By the time of settlement, more than 280,000 veterans had signed on.3Arizona State University Embryo Project Encyclopedia. In Re Agent Orange Product Liability Litigation
What the 1984 Settlement Paid Out
On May 7, 1984, Judge Weinstein brokered a $180 million settlement with all seven companies. A critical condition: the manufacturers admitted no liability.1Agent Orange Record. The US Lawsuit The class covered anyone in current or future generations at risk from their own or a parent’s exposure.3Arizona State University Embryo Project Encyclopedia. In Re Agent Orange Product Liability Litigation
The fund split into two programs. A Payment Program distributed $197 million in cash to roughly 52,000 veterans or their survivors; the maximum payout for a medically ill veteran was $12,800 spread over ten years, families of deceased veterans received $3,400, and the average payment worked out to about $3,800. A separate Class Assistance Program sent $74 million to 83 social service organizations serving about 239,000 veterans.1Agent Orange Record. The US Lawsuit The district court closed the fund on September 27, 1997.4U.S. Department of Veterans Affairs. Agent Orange Settlement Fund
To qualify for cash, a veteran had to have served in or near Vietnam between January 1, 1962, and December 31, 1971, be totally disabled before age 60 or be a survivor of a deceased veteran, pass a court-adopted exposure test, and show a death or disability not caused by accident or self-infliction and occurring before December 31, 1994.5Vietnam Veterans Against the War. Agent Orange Settlement
The deal was widely rejected by the plaintiffs it was meant to help. According to one contemporaneous account, more than 85 percent of veterans who provided testimony opposed the out-of-court deal, and critics faulted it for excluding children born with birth defects from direct payments. Jane Dziedzic, Reutershan’s sister, called it “a bittersweet victory.”5Vietnam Veterans Against the War. Agent Orange Settlement1Agent Orange Record. The US Lawsuit
Why Veterans Cannot Sue the Manufacturers Again
The Second Circuit affirmed the settlement on April 21, 1987. Writing for the panel, Circuit Judge Winter said the deal was justified “in light of both the pervasive difficulties faced by plaintiffs in establishing liability and our conviction that the military contractor defense absolved the chemical companies of any liability.” The same ruling dismissed claims against the United States under the Feres doctrine and upheld summary judgment against veterans who had opted out of the class.6Justia. In Re Agent Orange Product Liability Litigation, 818 F.2d 145
The Supreme Court then formalized the government contractor defense in Boyle v. United Technologies Corp. (1988). State tort claims are preempted when the government approved reasonably precise specifications, the product conformed to them, and the manufacturer warned the government about any known dangers.7Justia. Boyle v. United Technologies Corp., 487 U.S. 500
That defense proved decisive when veterans tried again. The 1984 settlement’s December 31, 1994, cutoff had left a large group of veterans out — those whose diseases appeared later. Daniel Stephenson, diagnosed with multiple myeloma in 1998, and Joe Isaacson, diagnosed with non-Hodgkin’s lymphoma in 1996, filed new suits. The Second Circuit ruled in November 2001 that the earlier settlement had inadequately represented future claimants and could not bar their cases.8FindLaw. Stephenson v. Dow Chemical Co. On remand, though, the cases were dismissed on the merits under the Boyle test. The Second Circuit affirmed in 2008, and the Supreme Court declined review in 2009.9International Crimes Database. Toxic Tort – Agent Orange
Dow, which absorbed Monsanto’s legacy liabilities, continues to say it and the other manufacturers were compelled to produce Agent Orange under the Defense Production Act of 1950, that the government controlled every aspect of its use, and that courts have “consistently ruled that Dow and the other manufacturers bear no responsibility.” The company also disputes any established causal link to cancer, birth defects, or transgenerational effects.10Dow. Agent Orange
The Vietnamese Plaintiffs’ Case
A separate suit by the Vietnam Association for Victims of Agent Orange and individual Vietnamese plaintiffs, filed in September 2004 under the Alien Tort Claims Act, ended the same way. Judge Weinstein dismissed the case in 2005 on the ground that Agent Orange was used as a herbicide rather than a weapon directed at people. The Second Circuit affirmed in February 2008, and the Supreme Court declined review in February 2009.11International Crimes Database. Vietnam Association for Victims of Agent Orange v. Dow
The Parallel Case Against the VA: Nehmer
While claims against the chemical companies dead-ended, a case against the federal government kept producing money for veterans. Nehmer v. U.S. Veterans Administration, a 1986 class action in the Northern District of California, produced a 1991 consent decree that binds the VA to this day. Whenever the VA adds a new disease to its Agent Orange presumptive list, it must find every veteran who previously filed a claim for that condition, readjudicate the claim, and pay benefits retroactive to the original filing date.12NVLSP. Policing the Promise
After the Ninth Circuit unanimously rejected a VA attempt to narrow the decree in 2007, the VA paid more than $4.6 billion in retroactive benefits to over 100,000 veterans and survivors. In the following eleven years, the National Veterans Legal Services Program forced another $97 million in payments to 4,000 veterans and survivors for further violations. Overall, decree enforcement has secured roughly $5 billion since 1986.12NVLSP. Policing the Promise13NVLSP. NVLSP Statement on VA OIG Report
The 2024 Inspector General Report
A June 2024 report from the VA’s Office of Inspector General found that the VA had failed to identify tens of thousands of veterans eligible for retroactive benefits after bladder cancer, hypothyroidism, and parkinsonism were added to the presumptive list through the 2021 National Defense Authorization Act. The OIG estimated 86,894 veterans met or potentially met Nehmer eligibility but were never identified, and that roughly 36,125 of them were entitled to about $836.8 million in unpaid benefits. Another 226 veterans with Camp Lejeune service were owed about $7.5 million.14VA Office of Inspector General. VBA Did Not Identify All Vietnam Veterans Who Could Qualify for Retroactive Benefits
The OIG traced the failure to data silos between the Veterans Benefits Administration and the Veterans Health Administration, and to claims processors who could not recall or apply the Nehmer procedures. By early 2025, the VA had closed two of the three OIG recommendations by updating screening procedures, but the recommendation to identify and readjudicate all missed claims remained open.15VA Office of Inspector General. VBA Did Not Identify All Vietnam Veterans Who Could Qualify for Retroactive Benefits Veterans with previously denied claims for those three conditions should not assume they have already been contacted.
Legislative Expansions of Eligibility
Blue Water Navy Vietnam Veterans Act of 2019
For decades, veterans who served on ships offshore Vietnam were denied the exposure presumption granted to those who set foot on land. The Blue Water Navy Vietnam Veterans Act, signed on June 25, 2019, extended the presumption to veterans who served within 12 nautical miles of the Vietnamese coast between January 9, 1962, and May 7, 1975. It took effect January 1, 2020, and also opened spina bifida benefits to children of qualifying Blue Water Navy veterans.16U.S. Department of Veterans Affairs. Blue Water Navy Veterans
The PACT Act of 2022
The PACT Act, signed in August 2022, was the broadest expansion of Agent Orange-related benefits in decades. It added high blood pressure and monoclonal gammopathy of undetermined significance (MGUS) to the presumptive condition list, and established five new presumptive exposure locations beyond Vietnam and Korea: U.S. and Royal Thai military bases in Thailand, Laos, parts of Cambodia, Guam and American Samoa, and Johnston Atoll.17U.S. Department of Veterans Affairs. Agent Orange Exposure and VA Disability Compensation18U.S. Department of Veterans Affairs. The PACT Act and Your VA Benefits As of February 2024, the VA was using PACT Act authorities to extend presumptive benefits to service locations in Canada, India, and 12 U.S. states, including Montana.19U.S. Senate Committee on Veterans’ Affairs. VA Moves to Expand Agent Orange Veterans Benefits Using Authorities From PACT Act In its first year, the VA processed 458,659 PACT Act-related claims and delivered more than $1.85 billion in benefits.
Conditions the VA Now Presumes Are Linked
The VA currently recognizes more than twenty conditions as presumptively linked to Agent Orange exposure:
- Cancers: bladder cancer, chronic B-cell leukemia, Hodgkin’s disease, multiple myeloma, non-Hodgkin’s lymphoma, prostate cancer, respiratory cancers (including lung cancer), and certain soft tissue sarcomas.
- Other conditions: AL amyloidosis, chloracne, type 2 diabetes, high blood pressure, hypothyroidism, ischemic heart disease, monoclonal gammopathy of undetermined significance, parkinsonism, Parkinson’s disease, early-onset peripheral neuropathy, and porphyria cutanea tarda.
Chloracne, early-onset peripheral neuropathy, and porphyria cutanea tarda must be at least 10 percent disabling within one year of exposure. Veterans previously denied for a condition now on the list may file a supplemental claim for a new review.17U.S. Department of Veterans Affairs. Agent Orange Exposure and VA Disability Compensation
The 2026 Sex Discrimination Lawsuit
The current legal front is a suit filed on April 27, 2026, by Vietnam veteran Ron Christoforo and his daughter Michele in the U.S. District Court for the District of Connecticut. Represented by Yale Law School’s Veterans Legal Services Clinic, they are challenging a provision of the Veterans Benefits and Health Care Improvement Act of 2000 that provides disability benefits for birth defects in children of female Vietnam veterans but excludes children of male veterans, with spina bifida as the only exception.20Military Times. Vietnam Veteran, Daughter Sue VA Over Agent Orange Birth Defect Benefits
Michele Christoforo has achondroplasia. Her father applied in 2022 for Agent Orange-related benefits on her behalf; the VA denied the claim, stating that only a mother’s service in Vietnam would qualify a child. The complaint argues the sex-based distinction violates the Fifth Amendment’s equal protection guarantee, citing the Supreme Court’s 2017 ruling in Sessions v. Morales-Santana.21Military.com. Vietnam Veteran and Daughter Sue VA for Agent Orange Birth Defect Benefits
The case is before District Judge Kari A. Dooley. As of June 2026, discovery is set to close October 27, 2026, with dispositive motions due December 1, 2026. The VA has not yet filed a response.22PACER Monitor. Christoforo et al v. United States Department of Veterans Affairs A related bill, the Agent Orange Relief Act of 2025, introduced by Representative Rashida Tlaib in April 2025, would extend the same benefits to children of male Vietnam veterans and fund research into intergenerational effects. It remains in committee.23U.S. Congress. H.R. 3052 – Agent Orange Relief Act of 2025
The most recent National Academies review, Veterans and Agent Orange: Update 11, released in November 2018, examined intergenerational effects and concluded the committee “did not find evidence of intergenerational effects, including birth defects, in the descendants of Vietnam Veterans resulting from exposure to any of the herbicides or their components.”24U.S. Department of Veterans Affairs. Health and Medicine Division Reports The Christoforo plaintiffs contend that more recent research supports a link between paternal exposure and genetic damage in offspring, and that finding will likely be contested in the case ahead.